Top

JA Clinical Reports

Published in:

Open Access 01-12-2021 | Malignant Hyperthermia | Letter to the Editor

General anesthesia with remimazolam in a patient with clinically suspected malignant hyperthermia

Authors: Keita Uchiyama, Hiroshi Sunaga, Nobuyuki Katori, Shoichi Uezono

Published in: JA Clinical Reports | Issue 1/2021

Excerpt

To the Editor, …

Gupta PK, Bilmen JG, Hopkins PM. Anaesthetic management of a known or suspected malignant hyperthermia susceptible patient. BJA Educ. 2021;21:218–24. https://doi.org/10.1016/j.bjae.2021.01.003.CrossRefPubMed

Watanabe T, Miyoshi H, Noda Y, Narasaki S, Morio A, Toyota Y, et al. Effects of Remimazolam and Propofol on Ca(2+) Regulation by Ryanodine Receptor 1 with Malignant Hyperthermia Mutation. Biomed Res Int. 2021;2021:8845129. https://doi.org/10.1155/2021/8845129.CrossRefPubMedPubMedCentral

GE Healthcare. Technical Report, https://www.gehealthcare.com/-/jssmedia/global/products/files/anesthesia-delivery/anesthesia-machine-malignant-hypothermia.pdf?rev=-1. Accessed 6 Sept 2021.

Mathews EL, Dhamee MS. Propofol in patients susceptible to malignant hyperthermia: a case report and review of the literature. J Clin Anesth. 1992;4:331–2. https://doi.org/10.1016/0952-8180(92)90141-m.CrossRefPubMed

Dewachter P, Kopac P, Laguna JJ, Mertes PM, Sabato V, Volcheck GW, et al. Anaesthetic management of patients with pre-existing allergic conditions: a narrative review. Br J Anaesth. 2019;123:e65–81. https://doi.org/10.1016/j.bja.2019.01.020.CrossRefPubMed

Doi M, Morita K, Takeda J, Sakamoto A, Yamakage M, Suzuki T. Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb/III trial. J Anesth. 2020;34:543–53. https://doi.org/10.1007/s00540-020-02788-6.CrossRefPubMed

Title: General anesthesia with remimazolam in a patient with clinically suspected malignant hyperthermia
Authors: Keita Uchiyama
Hiroshi Sunaga
Nobuyuki Katori
Shoichi Uezono
Publication date: 01-12-2021
Publisher: Springer Berlin Heidelberg
Keywords: Malignant Hyperthermia
Malignant Hyperthermia
General Anesthesia
Remifentanil
Flumazenil
Propofol
Rocuronium
Published in: JA Clinical Reports / Issue 1/2021
Electronic ISSN: 2363-9024
DOI: https://doi.org/10.1186/s40981-021-00482-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

General anesthesia with remimazolam in a patient with clinically suspected malignant hyperthermia

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2021

Intact survival from severe cardiogenic shock caused by the first attack of atrial tachycardia treated with extracorporeal membrane oxygenation and surgical left atrium appendage resection: a case report

Temporary worsening of mitral regurgitation due to conduction disturbance after transcatheter aortic valve implantation

Anesthetic management of multiple acyl-coenzyme A dehydrogenase deficiency in a series of surgeries under general anesthesia: a case report

An optimal epidural catheter placement site for post-cesarean section analgesia with double-space technique combined spinal–epidural anesthesia: a retrospective study

Delayed tracheal extubation after cardiac surgery due to cardiogenic ventilator auto-triggering: a case report

Acute limb ischemia by a pulmonary vein stump thrombus after left lower lobectomy: a case report